Details of the SBP
General Information of Synthetic Binding Protein (SBP) (ID: SBP000278) | ||||||
---|---|---|---|---|---|---|
SBP Name |
Macrocyclic peptide anti-AKT2 Pakti-L1
|
|||||
Synonyms |
Macrocyclic peptide Pakti-L1
|
|||||
Molecular Weight | 1.8 kDa | |||||
Design Method | Traditional methods (Site-directed mutagenesis and/or Directed evolution) | |||||
Expression System | FIT system | |||||
Selection Method | mRNA display | |||||
Highest Status | Research | |||||
Sequence Length | 14 | |||||
SBP Sequence |
>Macrocyclic peptide anti-AKT2 Pakti-L1
LYILVRNRLLRVDCG-NH2 |
|||||
Sequence Description | Ac and Cys form a bridge. | |||||
Protein Scaffold Information of This SBP | ||||||
---|---|---|---|---|---|---|
Scaffold ID | PS044 | [1] | ||||
Scaffold Name | Macrocyclic peptide | |||||
Scaffold Class | Non-Antibody | |||||
Fold Type | Beta-Sheets + Loops | |||||
Binding Target(s) of This SBP (BTS) |
---|
BTS Name | Details | Mechanism | Application | Affinity | Research Organization | Ref |
---|---|---|---|---|---|---|
RAC-beta serine/threonine-protein kinase | Inhibitor | Research tool | N.A. | The University of Tokyo | [1] | |